日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Shaping the battlefield: EGFR and KRAS tumor mutations' role on the immune microenvironment and immunotherapy responses in lung cancer

塑造战场:EGFR 和 KRAS 肿瘤突变在肺癌免疫微环境和免疫治疗反应中的作用

Alsaed, Bassel; Bobik, Nina; Laitinen, Hanna; Nandikonda, Tanvi; Ilonen, Ilkka; Haikala, Heidi M

Ex vivo modeling of precision immuno-oncology responses in lung cancer

肺癌精准免疫肿瘤学反应的体外模型

Alsaed, Bassel; Smolander, Johannes; Laitinen, Hanna; Lin, Linh; Bobik, Nina; Lahtinen, Lilja; Räsänen, Mikko; Jansouz, Shadi; Peltonen, Karita; Jokinen, Emmi; Klievink, Jay; Ganesh, Keerthana; Ainola, Mari; Sutinen, Eva; Rönty, Mikko; Narvi, Elli; Thotakura, Anil; Saharinen, Pipsa; Mustjoki, Satu; Ilonen, Ilkka; Haikala, Heidi M

Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release

CDK12 抑制可刺激 RNA 聚合酶 II 暂停释放,从而提高癌细胞对 P-TEFb 的依赖性

Zhijia Wang, Samu V Himanen, Heidi M Haikala, Caroline C Friedel, Anniina Vihervaara, Matjaž Barborič

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

一种针对非小细胞肺癌中耐药突变型 EGFR 的变构抑制剂

To, Ciric; Beyett, Tyler S; Jang, Jaebong; Feng, William W; Bahcall, Magda; Haikala, Heidi M; Shin, Bo H; Heppner, David E; Rana, Jaimin K; Leeper, Brittaney A; Soroko, Kara M; Poitras, Michael J; Gokhale, Prafulla C; Kobayashi, Yoshihisa; Wahid, Kamal; Kurppa, Kari J; Gero, Thomas W; Cameron, Michael D; Ogino, Atsuko; Mushajiang, Mierzhati; Xu, Chunxiao; Zhang, Yanxi; Scott, David A; Eck, Michael J; Gray, Nathanael S; Jänne, Pasi A

EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody-Drug Conjugate HER3-DXd

EGFR 抑制可增强 HER3 抗体-药物偶联物 HER3-DXd 的细胞摄取和抗肿瘤活性

Heidi M Haikala, Timothy Lopez, Jens Köhler, Pinar O Eser, Man Xu, Qing Zeng, Tyler J Teceno, Kenneth Ngo, Yutong Zhao, Elena V Ivanova, Arrien A Bertram, Brittaney A Leeper, Emily S Chambers, Anika E Adeni, Luke J Taus, Mari Kuraguchi, Paul T Kirschmeier, Channing Yu, Yoshinobu Shiose, Yasuki Kamai

Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer

非小细胞肺癌中 KRAS 突变的比较分析和异构体特异性治疗脆弱性

Biagio Ricciuti #, Jieun Son #, Jeffrey J Okoro, Alessia Mira, Enrico Patrucco, Yoonji Eum, Xinan Wang, Raymond Paranal, Haiyun Wang, Mika Lin, Heidi M Haikala, Jiaqi Li, Yue Xu, Joao Victor Alessi, Chhayheng Chhoeu, Amanda J Redig, Jens Köhler, Kshiti H Dholakia, Yunhan Chen, Elodie Richard, Marie-

Sortilin-related receptor is a druggable therapeutic target in breast cancer

分拣蛋白相关受体是乳腺癌的一个可用药物治疗靶点

Hussein Al-Akhrass, Mika Pietilä, Johanna Lilja, Ella-Maria Vesilahti, Johanna M Anttila, Heidi M Haikala, Pauliina M Munne, Juha Klefström, Emilia Peuhu, Johanna Ivaska

Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer

EGFR 突变肺癌亚组中致癌基因转换和单药 MET 抑制剂敏感性

Pınar Özden Eser, Raymond M Paranal, Jieun Son, Elena Ivanova, Yanan Kuang, Heidi M Haikala, Ciric To, Jeffrey J Okoro, Kshiti H Dholakia, Jihyun Choi, Yoonji Eum, Atsuko Ogino, Pavlos Missios, Dalia Ercan, Man Xu, Michael J Poitras, Stephen Wang, Kenneth Ngo, Michael Dills, Masahiko Yanagita, Timot

Thirty Years of HER3: From Basic Biology to Therapeutic Interventions

HER3三十年:从基础生物学到治疗干预

Haikala, Heidi M; Jänne, Pasi A

Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway

通过 YAP 介导的凋亡途径转录重编程,治疗诱导肿瘤休眠

Kari J Kurppa, Yao Liu, Ciric To, Tinghu Zhang, Mengyang Fan, Amir Vajdi, Erik H Knelson, Yingtian Xie, Klothilda Lim, Paloma Cejas, Andrew Portell, Patrick H Lizotte, Scott B Ficarro, Shuai Li, Ting Chen, Heidi M Haikala, Haiyun Wang, Magda Bahcall, Yang Gao, Sophia Shalhout, Steffen Boettcher, Bo